Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery

Sustainable Chemistry and Pharmacy

Volumn 6, Issue , 2017, Pages 37-56

  Ganesan, Poovi ^a,b   Narayanasamy, Damodharan ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b Government of Puducherry   (India)

Author keywords

Bioavailability; Hydrophobic drug; Nanostructured lipid carrier; Solid lipid nanoparticle

Indexed keywords

DRUG CARRIER; EXCIPIENT; LIPID; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; ORGANIC SOLVENT; SOLID LIPID NANOPARTICLE; SOLVENT; UNCLASSIFIED DRUG;

COACERVATION; COOLING; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; FREEZE DRYING; GREEN CHEMISTRY; MICROEMULSION; NEBULIZATION; PRIORITY JOURNAL; REVIEW; SUPERCRITICAL FLUID; TEMPERATURE;

EID: 85026833766     PISSN: None     EISSN: 23525541     Source Type: Journal    
DOI: 10.1016/j.scp.2017.07.002     Document Type: Review

References (205)

1. Abdelbary, G., Fahmy, R.H., Diazepam-loaded solid lipid nanoparticles: design and characterization. Aaps Pharmscitech 10 (2009), 211–219.
2. Agrawal, Y., Petkar, K.C., Sawant, K.K., Development, evaluation and clinical studies of acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int. J. Pharm. 401 (2010), 93–102.
3. Ahmed El-Harati, A., Charcosset, C., Fessi, H., Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor. Pharm. Dev. Technol. 11 (2006), 153–157.
4. Alex, M.A., Chacko, A., Jose, S., Souto, E., Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur. J. Pharm. Sci. 42 (2011), 11–18.
5. All Rights Are Reserved by Mrs., Gupta, D.R., 2009. Solubility Enhancement by Solid Lipid Nanoparticle.
6. Allison, S.D., Dc Molina, M., Anchordoquy, T.J., Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim. Biophys. Acta (BBA)-Biomembr. 1468 (2000), 127–138.
7. Almeida, A.J., Runge, S., Müller, R.H., Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int. J. Pharm. 149 (1997), 255–265.
8. Anastas, P.T., Warner, J.C., Green Chemistry Theory and Practice. 1998, Oxford University Press, New York, 30.
9. Angrick, M., Kümmerer, K., Meinzer, L., Nachhaltige Chemie: erfahrungen und Perspektiven. 2006, Metropolis Verlag für Ökonomie, Ges. Polit.
10. Anton, N., Benoit, J.-P., Saulnier, P., Design and production of nanoparticles formulated from nano-emulsion templates—a review. J. Control. Release 128 (2008), 185–199.
11. Araújo, J., Nikolic, S., Egea, M.A., Souto, E.B., Garcia, M.L., Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf. B: Biointerfaces 88 (2011), 150–157.
12. Basavaraj, K., Nanotechnology in medicine and relevance to dermatology: present concepts. Indian J. Dermatol., 57, 2012, 169.
13. Battaglia, L., Gallarate, M., Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin. Drug Deliv. 9 (2012), 497–508.
14. Battaglia, L., Trotta, M., Gallarate, M., Carlotti, M.E., Zara, G.P., Bargoni, A., Solid lipid nanoparticles formed by solvent-in-water emulsion–diffusion technique: development and influence on insulin stability. J. Microencapsul. 24 (2007), 672–684.
15. Battaglia, L., Gallarate, M., Cavalli, R., Trotta, M., Solid lipid nanoparticles produced through a coacervation method. J. Microencapsul. 27:1 (2010), 78–85.
16. Battaglia, L., Gallarate, M., Panciani, P.P., Ugazio, E., Sapino, S., Peira, E., Chirio, D., 2014. Techniques for the preparation of solid lipid nano and microparticles. In: Ali Demir Sezer, (Ed.), Application of Nanotechnology in Drug Delivery. InTech.
17. Benita, S., Böhm, B.H., Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs. 1998, CRC Press.
18. Bevilacqua, A., Cibelli, F., Corbo, M.R., Sinigaglia, M., Effects of high‐pressure homogenization on the survival of Alicyclobacillus acidoterrestris in a laboratory medium. Lett. Appl. Microbiol. 45:4 (2007), 382–386.
19. Bianco, M., Gallarate, M., Trotta, M., Battaglia, L., Amphotericin B loaded SLN prepared with the coacervation technique. J. Drug Deliv. Sci. Technol. 20 (2010), 187–191.
20. Bunjes, H., Westesen, K., Koch, M.H., Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int.J. Pharm. 129 (1996), 159–173.
21. Byrappa, K., Ohara, S., Adschiri, T., Nanoparticles synthesis using supercritical fluid technology–towards biomedical applications. Adv. Drug Deliv. Rev. 60:3 (2008), 299–327.
22. Cannon, A.S., Warner, J.C., The science of green chemistry and its role in educational reform. New Solut., 21(3), 2011, 499517.
23. Cavalli, R., Caputo, O., Carlotti, M.E., Trotta, M., Scarnecchia, C., Gasco, M.R., Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int. J. Pharm. 148 (1997), 47–54.
24. Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G.P., Gasco, M.R., Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J. Pharm. Sci. 92 (2003), 1085–1094.
25. Charcosset, C., El-Harati, A., Fessi, H., Preparation of solid lipid nanoparticles using a membrane contactor. J. Control. Release 108 (2005), 112–120.
26. Chattopadhyay, P., Huff, R., Shekunov, B.Y., Drug encapsulation using supercritical fluid extraction of emulsions. J. Pharm. Sci. 95 (2006), 667–679.
27. Chattopadhyay, P., Shekunov, B.Y., Yim, D., Cipolla, D., Boyd, B., Farr, S., Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv. Drug Deliv. Rev. 59 (2007), 444–453.
28. Chen, C.-C., Tsai, T.-H., Huang, Z.-R., Fang, J.-Y., Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur. J. Pharm. Biopharm. 74 (2010), 474–482.
29. Chen, G., Hou, S., Hu, P., Hu, Q., Guo, D., Xiao, Y., In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window. Nan Fang yi ke da xue xue bao = J. South. Med. Univ. 28 (2008), 1022–1024.
30. Chen-Yu, G., Chun-Fen, Y., Qi-Lu, L., Qi, T., Yan-Wei, X., Wei-Na, L., Guang-Xi, Z., Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 430 (2012), 292–298.
31. Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Serpe, L., Trotta, M., Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J. Microencapsul. 28 (2011), 537–548.
32. Cirri, M., Bragagni, M., Mennini, N., Mura, P., Development of a new delivery system consisting in “drug–in cyclodextrin–in nanostructured lipid carriers” for ketoprofen topical delivery. Eur. J. Pharm. Biopharm. 80 (2012), 46–53.
33. Conlin, A.K., Seidman, A.D., Bach, A., Lake, D., Dickler, M., D'andrea, G., Traina, T., Danso, M., Brufsky, A.M., Saleh, M., Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Clin. Breast Cancer 10 (2010), 281–287.
34. Crowe, J.H., Carpenter, J.F., Crowe, L.M., The role of vitrification in anhydrobiosis. Annu. Rev. Physiol. 60 (1998), 73–103.
35. Crowe, L.M., Crowe, J.H., Rudolph, A., Womersley, C., Appel, L., Preservation of freeze-dried liposomes by trehalose. Arch. Biochem. Biophys. 242 (1985), 240–247.
36. Crowe, L.M., Womersley, C., Crowe, J.H., Reid, D., Appel, L., Rudolph, A., Prevention of fusion and leakage in freeze-dried liposomes by carbohydrates. Biochim. Biophys. Acta (BBA)-Biomembr. 861 (1986), 131–140.
37. Das, S., Chaudhury, A., Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. Aaps Pharmscitech 12 (2011), 62–76.
38. Doktorovová, S., Araújo, J., Garcia, M.L., Rakovský, E., Souto, E.B., Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf. B: Biointerfaces 75 (2010), 538–542.
39. Domingo, C., Saurina, J., An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review. Anal. Chim. Acta 744 (2012), 8–22.
40. Emeje, M.O., Akpabio, E.I., Obidike, I.C., Ofoefule, S.I., Nanotechnology in Drug Delivery. 2012, INTECH Open Access Publisher.
41. Fang, J.-Y., Fang, C.-L., Liu, C.-H., Su, Y.-H., Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 70 (2008), 633–640.
42. Freitas, C., Müller, R., Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47 (1999), 125–132.
43. Gaba, B., Fazil, M., Ali, A., Baboota, S., Sahni, J.K., Ali, J., Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Del. 22 (2015), 691–700.
44. Galitsky, C., Chan, S.-C., Worrell, E., Masanet, E., Energy Efficiency Improvement and Cost Saving Opportunities for the Pharmaceutical Industry. An ENERGY STAR® Guide for Energy and Plant Managers (Report LBNL-57260)., 2008, Lawrence Berkeley National Laboratory, Berkeley, California.
45. Gallarate, M., Trotta, M., Battaglia, L., Chirio, D., Cisplatin-loaded SLN produced by coacervation technique. J. Drug Deliv. Sci. Technol. 20 (2010), 343–347.
46. Gasco, M.R., 1993. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents.
47. Gokce, E.H., Korkmaz, E., Dellera, E., Sandri, G., Bonferoni, M.C., Ozer, O., Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J. Nanomed. 7 (2012), 1841–1850.
48. Gonzalez-Mira, E., Egea, M., Garcia, M., Souto, E., Design ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf. B: Biointerfaces 81 (2010), 412–421.
49. Gupta, M., Vyas, S.P., Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem. Phys. Lipids 165 (2012), 454–461.
50. Gursoy, R.N., Benita, S., Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004), 173–182.
51. Hanafy, A., Spahn-Langguth, H., Vergnault, G., Grenier, P., Grozdanis, M.T., Lenhardt, T., Langguth, P., Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv. Drug Deliv. Rev. 59 (2007), 419–426.
52. Hanumanaik, M., Patel, S.K., Sree, K.R., Solid lipid nanoparticles; A review. IJPSR 4:3 (2013), 928–940.
53. Harde, H., Das, M., Jain, S., Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv. 8 (2011), 1407–1424.
54. Hauser, H., Strauss, G., Stabilization of Small, Unilamellar Phospholipid Vesicles by Sucrose During Freezing and Dehydration. Biotechnological Applications of Lipid Microstructures. 1988, Springer, Springer, Boston, MA, US, 71–80.
55. Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., Benoit, J.-P., A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19 (2002), 875–880.
56. Hu, F., Hong, Y., Yuan, H., Preparation and characterization of solid lipid nanoparticles containing peptide. Int. J. Pharm. 273 (2004), 29–35.
57. Hu, L., Tang, X., Cui, F., Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J. Pharm. Pharmacol. 56 (2004), 1527–1535.
58. Hu, L., Xing, Q., Meng, J., Shang, C., Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. Aaps Pharmscitech 11 (2010), 582–587.
59. Huang, Z.R., Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin. 29 (2008), 1094–1102.
60. Iqbal, M.A., Md, S., Sahni, J.K., Baboota, S., Dang, S., Ali, J., Nanostructured lipid carriers system: recent advances in drug delivery. J. Drug Target. 20 (2012), 813–830.
61. Izquierdo, P., Esquena, J., Tadros, T.F., Dederen, C., Garcia, M., Azemar, N., Solans, C., Formation and stability of nano-emulsions prepared using the phase inversion temperature method. Langmuir 18 (2002), 26–30.
62. Jaiswal, J., Gupta, S.K., Kreuter, J., Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J. Control. Release 96 (2004), 169–178.
63. Jaiswal, P., Gidwani, B., Vyas, A., Nanostructured lipid carriers and their current application in targeted drug delivery. Artif. Cells Nanomed. Biotechnol. 44 (2016), 27–40.
64. Jenning, V., Thünemann, A.F., Gohla, S.H., Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199 (2000), 167–177.
65. Jensen, L.B., Magnussson, E., Gunnarsson, L., Vermehren, C., Nielsen, H.M., Petersson, K., Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int. J. Pharm. 390 (2010), 53–60.
66. Jia, L., Zhang, D., Li, Z., Duan, C., Wang, Y., Feng, F., Wang, F., Liu, Y., Zhang, Q., Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf. B: Biointerfaces 80 (2010), 213–218.
67. Jorgensen, L., Nielson, H.M., Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines. 2009, Wiley, John Wiley & Sons Ltd, Chichester, United Kingdom.
68. Kakkar, V., Singh, S., Singla, D., Kaur, I.P., Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol. Nutr. Food Res. 55 (2011), 495–503.
69. Kang, K.W., Chun, M.-K., Kim, O., Subedi, R.K., Ahn, S.-G., Yoon, J.-H., Choi, H.-K., Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomed.: Nanotechnol. Biol. Med. 6 (2010), 210–213.
70. Kaur, Sarabjot, Nautyal, Ujjwal, Singh, Ramandeep, Singh, Satvinder, Devi, Anita, Nanostructure lipid carrier (NLC): the new generation of lipid nanoparticles. Asian Pac. J. Health Sci. 2:2 (2015), 76–93.
71. Kayser, O., Lemke, A., Hernandez-Trejo, N., The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol. 6 (2005), 3–5.
72. Kheradmandnia, S., Vasheghani-Farahani, E., Nosrati, M., Atyabi, F., Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomed.: Nanotechnol. Biol. Med. 6 (2010), 753–759.
73. Konwarh, R., Pramanik, S., Kalita, D., Mahanta, C.L., Karak, N., Ultrasonication–a complementary ‘green chemistry'tool to biocatalysis: a laboratory-scale study of lycopene extraction. Ultrason. Sonochem. 19:2 (2012), 292–299.
74. Koziara, J.M., Lockman, P.R., Allen, D.D., Mumper, R.J., Paclitaxel nanoparticles for the potential treatment of brain tumors. J. Control. Release 99:2 (2004), 259–269.
75. Koziara, J.M., Oh, J.J., Akers, W.S., Ferraris, S.P., Mumper, R.J., Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm. Res. 22:11 (2005), 1821–1828.
76. Kumar, M., Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. 3 (2000), 234–258.
77. Kumar, S., Dilbaghi, N., Saharan, R., Bhanjana, G., Nanotechnology as emerging tool for enhancing solubility of poorly water-soluble drugs. BioNanoScience 2 (2012), 227–250.
78. Kumar, V.V., Chandrasekar, D., Ramakrishna, S., Kishan, V., Rao, Y.M., Diwan, P.V., Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int. J. Pharm. 335 (2007), 167–175.
79. Kümmerer, K., Hempel, M., Green and Sustainable Pharmacy. 2010, Springer, Berlin.
80. Kuo, Y.-C., Chung, J.-F., Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf. B: Biointerfaces 83 (2011), 299–306.
81. Lander, R., Manger, W., Scouloudis, M., Ku, A., Davis, C., Lee, A., Gaulin homogenization: a mechanistic study. Biotechnol. Progress. 16 (2000), 80–85.
82. Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., Lou, H., Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 133 (2009), 238–244.
83. Lim, S.-J., Kim, C.-K., Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int. J. Pharm. 243 (2002), 135–146.
84. Lin, Y.-K., Huang, Z.-R., Zhuo, R.-Z., Fang, J.-Y., Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J. Nanomed. 5 (2010), 117–128.
85. Lippacher, A., Müller, R., Mäder, K., Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int. J. Pharm. 196 (2000), 227–230.
86. Liu, C., Liu, D., Bai, F., Zhang, J., Zhang, N., In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery. Drug Deliv. 17 (2010), 352–363.
87. Liu, C.-H., Wu, C.-T., Optimization of nanostructured lipid carriers for lutein delivery. Colloids Surf. A: Physicochem. Eng. Asp. 353 (2010), 149–156.
88. Liu, D., Liu, C., Zou, W., Zhang, N., Enhanced gastrointestinal absorption of N3-O-toluyl-fluorouracil by cationic solid lipid nanoparticles. J. Nanopart. Res. 12 (2010), 975–984.
89. Liu, D., Liu, Z., Wang, L., Zhang, C., Zhang, N., Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf. B: Biointerfaces 85 (2011), 262–269.
90. Luo, C.-F., Yuan, M., Chen, M.-S., Liu, S.-M., Zhu, L., Huang, B.-Y., Liu, X.-W., Xiong, W., Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int. J. Pharm. 410 (2011), 138–144.
91. Luo, Y., Chen, D., Ren, L., Zhao, X., Qin, J., Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 114 (2006), 53–59.
92. Ma, P., Dong, X., Swadley, C.L., Gupte, A., Leggas, M., Ledebur, H.C., Mumper, R.J., Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J. Biomed. Nanotechnol. 5 (2009), 151–161.
93. Madden, T.D., Bally, M.B., Hope, M.J., Cullis, P.R., Schieren, H.P., Janoff, A.S., Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim. Biophys. Acta (BBA)-Biomembr. 817 (1985), 67–74.
94. Mäder, K., Mehnert, W., Nastruzzi, C., Solid Lipid Nanoparticles—concepts, Procedures, and Physicochemical Aspect. Lipospheres in Drug Targets and Delivery: Approaches, methods, and Applications. 2004, CRC Press, Boca Raton, 1–22.
95. Malik, P., Shankar, R., Malik, V., Sharma, N., Mukherjee, T.K., Green chemistry based benign routes for nanoparticle synthesis. J. Nanopart., 2014.
96. Manjunath, K., Venkateswarlu, V., Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Control. Release 107 (2005), 215–228.
97. Manjunath, K., Venkateswarlu, V., Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Drug Target. 14 (2006), 632–645.
98. Manjunath, K., Reddy, J.S., Venkateswarlu, V., Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol. 27 (2005), 127–144.
99. Markarian, J., Reducing the environmental impact of manufacturing. Pharm. Technol. 40 (2016), 36–38.
100. Martins, S., Sarmento, B., Ferreira, D.C., Souto, E.B., Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles. Int. J. Nanomed., 2, 2007, 595.
101. Martins, S., Silva, A., Ferreira, D., Souto, E., Improving oral absorption of samon calcitonin by trimyristin lipid nanoparticles. J. Biomed. Nanotechnol. 5 (2009), 76–83.
102. Medina-González, Y., Aimar, P., Lahitte, J.F., Remigy, J.C., Towards green membranes: preparation of cellulose acetate ultrafiltration membranes using methyl lactate as a biosolvent. Int. J. Sustain. Eng. 4:01 (2011), 75–83.
103. Mehnert, W., Mäder, K., Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001), 165–196.
104. Mei, Z., Li, X., Wu, Q., Hu, S., Yang, X., The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Pharmacol. Res. 51 (2005), 345–351.
105. Mishra, D.K., Dhote, V., Bhatnagar, P., Mishra, P.K., Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research. Drug Deliv. Transl. Res. 2 (2012), 238–253.
106. Mobley, W.C., Schreier, H., Phase transition temperature reduction and glass formation in dehydroprotected lyophilized liposomes. J. Control. Release 31 (1994), 73–87.
107. Montenegro, L., Campisi, A., Sarpietro, M.G., Carbone, C., Acquaviva, R., Raciti, G., Puglisi, G., In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev. Ind. Pharm. 37 (2011), 737–746.
108. Muchow, M., Maincent, P., Müller, R.H., Lipid nanoparticles with a solid matrix (SLN®, NLC®, LDC®) for oral drug delivery. Drug Dev. Ind. Pharm. 34 (2008), 1394–1405.
109. Mudshinge, S.R., Deore, A.B., Patil, S., Bhalgat, C.M., Nanoparticles: emerging carriers for drug delivery. Saudi Pharm. J. 19 (2011), 129–141.
110. Muèller, R.H., Maèder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000), 161–177.
111. Müller, R., Maaben, S., Weyhers, H., Mehnert, W., Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target. 4 (1996), 161–170.
112. Müller, R., Maassen, S., Schwarz, C., Mehnert, W., Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J. Control. Release 47 (1997), 261–269.
113. Müller, R., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A., Souto, E., Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int. J. Pharm. 317 (2006), 82–89.
114. Müller, R., Runge, S., Ravelli, V., Thünemann, A., Mehnert, W., Souto, E., Cyclosporine-loaded solid lipid nanoparticles (SLN®): drug–lipid physicochemical interactions and characterization of drug incorporation. Eur. J. Pharm. Biopharm. 68 (2008), 535–544.
115. Müller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (2002), S131–S155.
116. Mumper Russell John, Michael Jay, 2006. Microemulsions as Precursors to Solid Nanoparticles. U.S. Patent No. 7,153,525. 26 Dec.
117. Nam, S.-H., Ji, X.Y., Park, J.-S., Investigation of tacrolimus loaded nanostructured lipid carriers for topical drug delivery. Bull. Korean Chem. Soc. 32 (2011), 956–960.
118. Nayak, A.P., Tiyaboonchai, W., Patankar, S., Madhusudhan, B., Souto, E.B., Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf. B: Biointerfaces 81 (2010), 263–273.
119. Obeidat, W.M., Schwabe, K., Müller, R.H., Keck, C.M., Preservation of nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 76 (2010), 56–67.
120. O'driscoll, C., Griffin, B., Biopharmaceutical challenges associated with drugs with low aqueous solubility—the potential impact of lipid-based formulations. Adv. Drug Deliv. Rev. 60 (2008), 617–624.
121. Paliwal, R., Rai, S., Vaidya, B., Khatri, K., Goyal, A.K., Mishra, N., Mehta, A., Vyas, S.P., Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomed.: Nanotechnol. Biol. Med. 5 (2009), 184–191.
122. Pandey, R., Sharma, S., Khuller, G., Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis 85 (2005), 415–420.
123. Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H., Plank, H., Zimmer, A., Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int. J. Pharm. 419 (2011), 329–338.
124. Pardeshi, C., Rajput, P., Belgamwar, V., Tekade, A., Patil, G., Chaudhary, K., Sonje, A., Solid lipid based nanocarriers: an overview/Nanonosači na bazi čvrstih lipida: pregled. Acta Pharm. 62 (2012), 433–472.
125. Pathak, K., Raghuvanshi, S., Oral bioavailability: issues and solutions via nanoformulations. Clin. Pharmacokinet. 54 (2015), 325–357.
126. Pathak, P., Nagarsenker, M., Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. Aaps Pharmscitech, 10, 2009, 985.
127. Pathak, P., Nagarsenker, M., Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. Aaps Pharmscitech 10 (2009), 985–992.
128. Pedersen, N., Hansen, S., Heydenreich, A.V., Kristensen, H.G., Poulsen, H.S., Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur. J. Pharm. Biopharm. 62 (2006), 155–162.
129. Phan, C.T., Tso, P., Intestinal lipid absorption and transport. Front. Biosci.: J. Virtual Libr. 6 (2001), D299–D319.
130. Poovi, G., Challenges and advances in solid lipid nanoparticle drug delivery systems. J. Pharm. Care Health Syst., 3(Suppl.), 2016, S2.
131. Porter, C.J., Charman, W.N., Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 50 (2001), 61–80.
132. Porter, C.J., Trevaskis, N.L., Charman, W.N., Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6 (2007), 231–248.
133. Potta, S.G., Minemi, S., Nukala, R.K., Peinado, C., Lamprou, D.A., Urquhart, A., Douroumis, D., Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. J. Microencapsul. 28 (2011), 74–81.
134. Priano, L., Zara, G.P., El-Assawy, N., Cattaldo, S., Muntoni, E., Milano, E., Serpe, L., Musicanti, C., Pérot, C., Gasco, M.R., Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration. Eur. J. Pharm. Biopharm. 79 (2011), 135–141.
135. Puglia, C., Sarpietro, M.G., Bonina, F., Castelli, F., Zammataro, M., Chiechio, S., Development, characterization, and in vitro and in vivo evaluation of benzocaine‐and lidocaine‐loaded nanostructrured lipid carriers. J. Pharm. Sci. 100 (2011), 1892–1899.
136. Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., Blumenthal, R., Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit. Rev.™ Ther. Drug Carr. Syst., 2009, 26.
137. Rajagopal, R., Sustainable Value Creation in the Fne and Speciality Chemicals Industry. 2014, John Wiley & Sons Ltd., United kingdom.
138. Rao, K.K., 2008. Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides. Google Patents.
139. Rawat, M.K., Jain, A., Singh, S., Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. J. Pharm. Sci. 100 (2011), 2366–2378.
140. Reverchon, E., Porta, G.D., Supercritical fluids-assisted micronization techniques. Low-impact routes for particle production. Pure Appl. Chem. 73:8 (2001), 1293–1297.
141. Ricci, M., Puglia, C., Bonina, F., Giovanni, C.D., Giovagnoli, S., Rossi, C., Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J. Pharm. Sci. 94 (2005), 1149–1159.
142. Ruktanonchai, U., Bejrapha, P., Sakulkhu, U., Opanasopit, P., Bunyapraphatsara, N., Junyaprasert, V., Puttipipatkhachorn, S., Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. Aaps Pharmscitech 10 (2009), 227–234.
143. Salmaso, S., Elvassore, N., Bertucco, A., Caliceti, P., Production of solid lipid submicron particles for protein delivery using a novel supercritical gas‐assisted melting atomization process. J. Pharm. Sci. 98:2 (2009), 640–650.
144. Sanad, R.A., Abdelmalak, N.S., Badawi, A.A., Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). Aaps Pharmscitech 11 (2010), 1684–1694.
145. Sanjula, B., Shah, F.M., Javed, A., Alka, A., Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J. Drug Target. 17 (2009), 249–256.
146. Sarmento, B., Martins, S., Ferreira, D., Souto, E.B., Oral insulin delivery by means of solid lipid nanoparticles. Int. J. Nanomed., 2, 2007, 743.
147. Sawant, K.K., Varia, J.K., Dodiya, S.S., Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization. Curr. Drug Deliv. 5 (2008), 64–69.
148. Schäfer-Korting, M., Drug Delivery. 2010, Springer, Berlin, Heidelberg.
149. Schubert, M., Müller-Goymann, C., Solvent injection as a new approach for manufacturing lipid nanoparticles–evaluation of the method and process parameters. Eur. J. Pharm. Biopharm. 55 (2003), 125–131.
150. Schwarz, C., Mehnert, W., Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int. J. Pharm. 157 (1997), 171–179.
151. Schwarz, C., Mehnert, W., Lucks, J., Müller, R., Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release 30 (1994), 83–96.
152. Seetapan, N., Bejrapha, P., Srinuanchai, W., Ruktanonchai, U.R., Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). Micron 41 (2010), 51–58.
153. Shah, R., Eldridge, D., Palombo, E., Harding, I., Lipid Nanoparticles: Production, Characterization and Stability. 2015, Springer International Publishing.
154. Shahgaldian, P., Da Silva, E., Coleman, A.W., Rather, B., Zaworotko, M.J., Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int. J. Pharm. 253 (2003), 23–38.
155. Shahgaldian, P., Gualbert, J., Aı̈Ssa, K.S., Coleman, A.W., A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 55 (2003), 181–184.
156. Shahgaldian, P., Quattrocchi, L., Gualbert, J., Coleman, A.W., Goreloff, P., AFM imaging of calixarene based solid lipid nanoparticles in gel matrices. Eur. J. Pharm. Biopharm. 55 (2003), 107–113.
157. Shiau, Y., Mechanism of intestinal fatty acid uptake in the rat: the role of an acidic microclimate. J. Physiol., 421, 1990, 463.
158. Shulkin, P.M., Seltzer, S.E., Davis, M.A., Adams, D.F., Lyophilized liposomes: a new method for long-term vesicular storage. J. Microencapsul. 1 (1984), 73–80.
159. Silva, A., Santos, D., Ferreira, D., Souto, F., Oral delivery of drugs by means of solid lipid nanoparticles. Minerva Biotecnol., 19, 2007, 1.
160. Silva, A., González-Mira, E., García, M., Egea, M., Fonseca, J., Silva, R., Santos, D., Souto, E., Ferreira, D., Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf. B: Biointerfaces 86 (2011), 158–165.
161. Sjöström, B., Bergenståhl, B., Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm. 88 (1992), 53–62.
162. Souto, E., Muller, R., Application of lipid nanoparticles (SLN and NLC) in food industry. J. Food Technol. 4 (2006), 90–95.
163. Souto, E., Wissing, S., Barbosa, C., Müller, R., Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 58 (2004), 83–90.
164. Souto, E.B., Muller, R., Lipid nanoparticles (solid lipid nanoparticles and nanostructured lipid carriers) for cosmetic, dermal, and transdermal applications. DRUGS Pharm. Sci., 166, 2007, 213.
165. Souto, E.B., Müller, R.H., Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Schäfer-Korting, M., (eds.) Drug Delivery, 2010, Springer Berlin Heidelberg, Berlin, Heidelberg, 115–141.
166. Souza, L., Silva, E., Martins, A., Mota, M., Braga, R., Lima, E., Valadares, M., Taveira, S., Marreto, R., Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur. J. Pharm. Biopharm. 79 (2011), 189–196.
167. Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C.C., Seltmann, H., Korting, H.C., Kramer, K.D., Schäfer-Korting, M., Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res. 24 (2007), 991–1000.
168. Strauss, G., Schurtenberger, P., Hauser, H., The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying. Biochim. Biophys. Acta (BBA)-Biomembr. 858 (1986), 169–180.
169. Subedi, R.K., Kang, K.W., Choi, H.-K., Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur. J. Pharm. Sci. 37 (2009), 508–513.
170. Suresh, G., Manjunath, K., Venkateswarlu, V., Satyanarayana, V., Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. Aaps Pharmscitech 8 (2007), E162–E170.
171. Svilenov, H., Tzachev, C., Solid lipid nanoparticles–a promising drug delivery system. Nanomed. One Cent. Press Manch., 2014, 187–237.
172. Swathi, G., Prasanthi, N., Manikiran, S., Ramarao, N., Solid lipid nanoparticles: colloidal carrier systems for drug delivery. ChemInform, 43, 2012 (no).
173. Swathi, M.P., Bala, P., A review on solid lipid nanoparticles. Int. J. Pharm. Sci. Rev. Res 20:2 (2013), 196–206 (36).
174. Tan, S., Billa, N., Roberts, C., Burley, J., Surfactant effects on the physical characteristics of amphotericin B-containing nanostructured lipid carriers. Colloids Surf. A: Physicochem. Eng. Asp. 372 (2010), 73–79.
175. Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O.B., Minko, T., Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J. Control. Release 171 (2013), 349–357.
176. Teeranachaideekul, V., Souto, E.B., Müller, R.H., Junyaprasert, V.B., Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels). J. Microencapsul. 25 (2008), 111–120.
177. Thatipamula, R., Palem, C., Gannu, R., Mudragada, S., Yamsani, M., Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. Daru 19 (2011), 23–32.
178. Trotta, M., Debernardi, F., Caputo, O., Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique. Int. J. Pharm. 257 (2003), 153–160.
179. Tsai, M.J., Huang, Y.B., Wu, P.C., Fu, Y.S., Kao, Y.R., Fang, J.Y., Tsai, Y.H., Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J. Pharm. Sci. 100 (2011), 547–557.
180. Üner, M., Yener, G., Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomed., 2, 2007, 289.
181. Unruh, T., Bunjes, H., Westesen, K., Koch, M., Investigations on the melting behaviour of triglyceride nanoparticles. Colloid Polym. Sci. 279 (2001), 398–403.
182. Varshosaz, J., Minayian, M., Moazen, E., Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. J. Liposome Res. 20 (2010), 115–123.
183. Varshosaz, J., Tabbakhian, M., Mohammadi, M.Y., Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J. Liposome Res. 20 (2010), 286–296.
184. Vezzù, K., Borin, D., Bertucco, A., Bersani, S., Salmaso, S., Caliceti, P., Production of lipid microparticles containing bioactive molecules functionalized with PEG. J. Supercrit. Fluids 54:3 (2010), 328–334.
185. Voutchkova-Kostal, A.M., Kostal, J., Connors, K.A., Brooks, Bryan W., Anastas, P.T., Zimmerman, J.B., Towards rational molecular design for reduced chronic aquatic toxicity. Green. Chem. 14 (2012), 1001–1008.
186. Waghmare, A., Grampurohit, N., Gadhave, M., Gaikwad, D., Jadhav, S., Solid lipid nanoparticles: a promising drug delivery. Int. Res. J. Pharm. 3:4 (2012), 100–107.
187. Wang, G., Wang, J., Wu, W., Tony To, S.S., Zhao, H., Wang, J., Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs. Expert Opin. Drug Deliv. 12 (2015), 1475–1499.
188. Westesen, K., Bunjes, H., Koch, M., Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 48 (1997), 223–236.
189. Wissing, S., Kayser, O., Müller, R., Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56 (2004), 1257–1272.
190. Wissing, S.A., Müller, R.H., The influence of solid lipid nanoparticles on skin hydration and viscoelasticity–in vivo study. Eur. J. Pharm. Biopharm. 56 (2003), 67–72.
191. Wu, L., Zhang, J., Watanabe, W., Physical and chemical stability of drug nanoparticles. Adv. Drug Deliv. Rev. 63 (2011), 456–469.
192. Xie, S., Pan, B., Wang, M., Zhu, L., Wang, F., Dong, Z., Wang, X., Zhou, W., Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles. Nanomedicine 5 (2010), 693–701.
193. Xie, S., Zhu, L., Dong, Z., Wang, X., Wang, Y., Li, X., Zhou, W., Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids. Colloids Surf. B: Biointerfaces 83 (2011), 382–387.
194. Xu, X.-M., Wang, Y.-S., Chen, R.-Y., Feng, C.-L., Yao, F., Tong, S.-S., Wang, L., Yamashita, F., Yu, J.-N., Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice. Chem. Pharm. Bull. 59 (2011), 260–265.
195. Yadav, N., Khatak, S., Sara, U.V.S., Solid lipid nanoparticles–a review. Int. J. Appl. Pharm. 5 (2013), 8–18.
196. Yang, R., Gao, R., Li, F., He, H., Tang, X., The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev. Ind. Pharm. 37 (2011), 139–148.
197. Yang, S., Zhu, J., Lu, Y., Liang, B., Yang, C., Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res. 16 (1999), 751–757.
198. Yuan, H., Chen, J., Du, Y.-Z., Hu, F.-Q., Zeng, S., Zhao, H.-L., Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf. B: Biointerfaces 58 (2007), 157–164.
199. Yuan, H., Wang, L.-L., Du, Y.-Z., You, J., Hu, F.-Q., Zeng, S., Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B: Biointerfaces 60 (2007), 174–179.
200. Zara, G.P., Bargoni, A., Cavalli, R., Fundarò, A., Vighetto, D., Gasco, M.R., Pharmacokinetics and tissue distribution of idarubicin‐loaded solid lipid nanoparticles after duodenal administration to rats. J. Pharm. Sci. 91 (2002), 1324–1333.
201. Zhang, N., Ping, Q., Huang, G., Xu, W., Cheng, Y., Han, X., Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int. J. Pharm. 327 (2006), 153–159.
202. Zhang, T., Chen, J., Zhang, Y., Shen, Q., Pan, W., Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur. J. Pharm. Sci. 43 (2011), 174–179.
203. Zhang, X., Pan, W., Gan, L., Zhu, C., Gan, Y., Nie, S., Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem. Pharm. Bull. 56 (2008), 1645–1650.
204. Zhang, X., Liu, J., Qiao, H., Liu, H., Ni, J., Zhang, W., Shi, Y., Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technol. 197 (2010), 120–128.
205. Zur Mühlen, A., Schwarz, C., Mehnert, W., Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur. J. Pharm. Biopharm. 45 (1998), 149–155.